These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 23636013

  • 1. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
    Chung SY, Lee JS, Lee H, Park SH, Kim SJ, Ryu HS.
    Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013
    [Abstract] [Full Text] [Related]

  • 2. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
    Joo JY, Park JY, Yoon YH, Choi B, Kim JM, Jo YS, Shong M, Koo BS.
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
    [Abstract] [Full Text] [Related]

  • 3. Preoperative BRAF mutation has different predictive values for lymph node metastasis according to tumor size.
    So YK, Son YI, Park JY, Baek CH, Jeong HS, Chung MK.
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):422-7. PubMed ID: 21750338
    [Abstract] [Full Text] [Related]

  • 4. BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience.
    Galuppini F, Pennelli G, Vianello F, Censi S, Zambonin L, Watutantrige-Fernando S, Manso J, Nacamulli D, Lora O, Pelizzo MR, Rugge M, Barollo S, Mian C.
    Clin Chem Lab Med; 2016 Sep 01; 54(9):1531-9. PubMed ID: 26863344
    [Abstract] [Full Text] [Related]

  • 5. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L, Shindo M, Schuff K, Corless C.
    Arch Otolaryngol Head Neck Surg; 2012 Jan 01; 138(1):44-9. PubMed ID: 22249628
    [Abstract] [Full Text] [Related]

  • 6. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.
    Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, Kim JS.
    Surgery; 2015 Dec 01; 158(6):1500-11. PubMed ID: 26120069
    [Abstract] [Full Text] [Related]

  • 7. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
    Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C.
    Clin Chem Lab Med; 2011 Feb 01; 49(2):325-9. PubMed ID: 21175381
    [Abstract] [Full Text] [Related]

  • 8. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.
    Diagn Cytopathol; 2015 Oct 01; 43(10):786-90. PubMed ID: 26152656
    [Abstract] [Full Text] [Related]

  • 9. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
    Colanta A, Lin O, Tafe L, Ghossein R, Nafa K, Mitchell T, Ladanyi M, Arcila M.
    Acta Cytol; 2011 Oct 01; 55(6):563-9. PubMed ID: 22156467
    [Abstract] [Full Text] [Related]

  • 10. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
    Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ, Qu JM.
    Ann Surg Oncol; 2010 Dec 01; 17(12):3294-300. PubMed ID: 20953721
    [Abstract] [Full Text] [Related]

  • 11. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
    Howell GM, Nikiforova MN, Carty SE, Armstrong MJ, Hodak SP, Stang MT, McCoy KL, Nikiforov YE, Yip L.
    Ann Surg Oncol; 2013 Jan 01; 20(1):47-52. PubMed ID: 22941165
    [Abstract] [Full Text] [Related]

  • 12. The thyroid imaging reporting and data system on US, but not the BRAFV600E mutation in fine-needle aspirates, is associated with lateral lymph node metastasis in PTC.
    Park VY, Kim EK, Moon HJ, Yoon JH, Kwak JY.
    Medicine (Baltimore); 2016 Jul 01; 95(29):e4292. PubMed ID: 27442672
    [Abstract] [Full Text] [Related]

  • 13. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.
    Head Neck; 2015 Dec 01; 37(12):1788-93. PubMed ID: 24989827
    [Abstract] [Full Text] [Related]

  • 14. Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma.
    Brahma B, Yulian ED, Ramli M, Setianingsih I, Gautama W, Brahma P, Sastroasmoro S, Harimurti K.
    Asian Pac J Cancer Prev; 2013 Dec 01; 14(1):31-7. PubMed ID: 23534744
    [Abstract] [Full Text] [Related]

  • 15. Predictive Value of BRAFV600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis.
    Song JY, Sun SR, Dong F, Huang T, Wu B, Zhou J.
    Curr Med Sci; 2018 Oct 01; 38(5):785-797. PubMed ID: 30341513
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C, Guo Y, Lv Y, Nanding A, Shi T, Qin H, He J.
    PLoS One; 2016 Oct 01; 11(12):e0167414. PubMed ID: 27936049
    [Abstract] [Full Text] [Related]

  • 17. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
    Zimmermann AK, Camenisch U, Rechsteiner MP, Bode-Lesniewska B, Rössle M.
    Cancer Cytopathol; 2014 Jan 01; 122(1):48-58. PubMed ID: 24039206
    [Abstract] [Full Text] [Related]

  • 18. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH, Kim BS, Kang KH, Kim HS.
    World J Surg Oncol; 2017 Nov 13; 15(1):202. PubMed ID: 29132392
    [Abstract] [Full Text] [Related]

  • 19. Integrating US-guided FNAB, BRAFV600E mutation, and clinicopathologic characteristics to predict cervical central lymph-node metastasis in preoperative patients with cN0 papillary thyroid carcinoma.
    Ma N, Tian HY, Yu ZY, Zhu X, Zhao DW.
    Eur Arch Otorhinolaryngol; 2023 Dec 13; 280(12):5565-5574. PubMed ID: 37540271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.